Merete Hædersdal
Bispebjerg Hospital
Department of Dermatology
Nielsine Nielsens Vej 17, opg. 4
2400 Copenhagen NV.
Denmark
University of Copenhagen
Institute for Clinical Medicine
Blegdamsvej 3B
2200 Copenhagen N.
Denmark
Current research
My major research interest is laser therapy in dermatology and the overall goal of my research is to translate experimental basic science into clinical benefit for large groups of patients to fight skin cancer. My own research Team in Copenhagen comprises a total of 19 researchers, focusing on integrating energy-based devices in dermatology and developing new tretments to patients with dermatological diseases.
For more than a decade, I have been affiliated with Massachusetts General Hospital, Harvard Medical School, pioneering a new treatment concept “laser-assisted drug delivery”, which is now world-wide taken into clinical practice. Non-invasive medical imaging techniques represent a cornerstone in our research to understand and develop new treatments to patients with skin cancer and other dermatological diseases.
Main interests
- Skin cancer
- Laser dermatology
- Translational research
- Laser assisted drug uptake
Short description
I spearhead the Danish Research Center for Skin Cancer and SCIN-CAG, two national consortiums dedicated to fighting skin cancer within multispecialty collaborations.
Appointed member - Danish multidisciplinary non-melanoma skin cancer group, https://www.dmcg.dk/
Visiting scientist / research staff, Wellman center for Photomedicine, Massachusetts General Hospital, Harvard medical School, Boston, USA.
Awards: Leon Goldman Memorial Award 2022 / American Society for Laser Medicine and Surgery (ASLMS); Danish Dermatological Society honorary grant; Ellet H Drake Memorial Award / American Society for Lasers in Medicine and Surgery; and Mentorship & Public Advocacy for Women in Medical Science / ASLMS
Doctoral dissertation
Title:
Cutaneous side effects from laser treatment of the skin: Skin cancer, scars, wounds, pigmentary changes, and purpura - use of pulsed dye laser, copper vapor laser, and argon laser.
Enrollment:
University of Copenhagen
Year:
1999
PhD thesis
Title:
Side effects from dermatological laser treatment. The importance of anti-inflammatory drugs, ultraviolet irradiation, and skin pigmentation.
Enrollment:
University of Copenhagen
Year:
1997
Publications
Wenande E, Hendel K, Mogensen M, Bagger C, Mårtensson NL, Persson DP, Lerche CM, Husted S, Janfelt C, Togsverd-Bo K, Anderson RR, Haedersdal M. Efficacy and Safety of Laser-Assisted Combination Chemotherapy: An Explorative Imaging-Guided Treatment With 5-Fluorouracil and Cisplatin for Basal Cell Carcinoma. Lasers Surg Med. 2021 Jan;53(1):119-128.
Fontenete S, Lerche CM, Paasch U, Perez-Moreno M, Olesen UH, Haedersdal M. Tumor Clearance and Immune Cell Recruitment in UV-Induced Murine Squamous Cell Carcinoma Exposed to Ablative Fractional Laser and Imiquimod Treatment. Laser Surg Med. 2021 Nov;53(9):1227-1237.
Larsen HK, Hædersdal M, Thomsen LT, Hertzum-Larsen R, Lok TT, Bonde J, Sørensen SS, Hansen JM, Palefsky JM, Kjær SK. Risk of anal high-grade squamous intraepithelial lesions among renal transplant recipients compared with immunocompetent controls. Clin Infect Dis. 2021 Jul 1;73(1):21-29.
Olesen UH, Clergeaud G, Hendel KK, Yeung K, Lerche CM, Andresen TL, Haedersdal M. Enhanced and Sustained Cutaneous Delivery of Vismodegib by Ablative Fractional Laser and Microemulsion Formulation. J Invest Dermatol. 2020 Oct;140(10):2051-2059.
Erlendsson AM, Olesen UH, Haedersdal M, Rossi AM. Ablative fractional laser-assisted treatments for keratinocyte carcinomas and its precursors-Clinical review and future perspectives. Adv Drug Deliv Rev. 2020 Jan 1;153:185-194.
Publications and releases
Related employees
